Janssen\'s esketamine recommended by FDA panel for depressionFeature Can AI solve the drug development problemFMD would not apply in case of nodeal BrexitGilead\'s CART therapy Yescarta rejected for NHS use in Scotland Last week\'s TOP 10

-Janssen's esketamine recommended by #FDA panel for #depression -Feature: Can #AI solve the drug development problem? -#FMD would not apply in case of no-deal #Brexit -Gilead's CAR-T therapy #Yescarta rejected for #NHS use in Scotland Last week's TOP 10

-Janssen's esketamine recommended by #FDA panel for #depression -Feature: Can #AI solve the drug development problem? - #FMD would not apply in case of no-deal #Brexit -Gilead's CAR-T therapy #Yescarta rejected for #NHS use in Scotland Last week's TOP 10 http://bit.ly/2SyTl41  pic.twitter.com/99Trb8h5f8

More From BioPortfolio on "-Janssen's esketamine recommended by #FDA panel for #depression -Feature: Can #AI solve the drug development problem? -#FMD would not apply in case of no-deal #Brexit -Gilead's CAR-T therapy #Yescarta rejected for #NHS use in Scotland Last week's TOP 10 "